There was a clear trend: patients in the 10–14 or > 14 drug groups had more DRPs, whereas those in the < 5 or 5–9 drug groups had fewer DRPs.
← all excerpts
Prevalence and associated factors for drug-related problems and polypharmacy identified by a pharmacist-led medication review in patients enrolled in a home healthcare program.
1
—
—